1-6 of 6
Ove Juul Nielsen
Close
Sort by
Journal Articles

Asparaginase-Associated Pancreatitis in ALL: Results from the NOPHO ALL2008 Treatment of Patients 1-45 Years

Cecilie Utke Rank, MD, Benjamin Ole Wolthers, MD, Kathrine Grell, PhD, Birgitte Klug Albertsen, MD, Thomas Leth Frandsen, MD PhD, Ulrik Malthe Overgaard, MD, Nina Toft, MD PhD, Ove Juul Nielsen, MD DMSc, Peder Skov Wehner, MD, Arja Harila-Saari, Mats Heyman, MD PhD, Jonas Abrahamsson, Ulrika Norén-Nyström, MD PhD, Beata Tomaszewska-Toporska, MD, Bendik Lund, MD PhD, Kirsten Brunsvig Jarvis, MD, Petter Quist-Paulsen, MD PhD, Goda Elizabeta Vaitkeviciene, MD PhD, Laimonas Griškevičius, MD PhD, Mervi Taskinen, MD PhD, Ulla Wartiovaara-Kautto, MD PhD, Kristi Lepik, MD, Mari Punab, MD, Ólafur Gísli Jónsson, MD PhD, Kjeld Schmiegelow, MD DMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3820.
https://doi.org/10.1182/blood-2019-122275
Published: 2019
Journal Articles

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Clinical Trials & Observations
Cecilie Utke Rank, Nina Toft, Ruta Tuckuviene, Kathrine Grell, Ove Juul Nielsen, Thomas Leth Frandsen, Hanne Vibeke Hansen Marquart, Birgitte Klug Albertsen, Ulf Tedgård, Helene Hallböök, Ellen Ruud, Kirsten Brunsvig Jarvis, Petter Quist-Paulsen, Pasi Huttunen, Ulla Wartiovaara-Kautto, Ólafur Gísli Jónsson, Sonata Saulyte Trakymiene, Laimonas Griškevičius, Kadri Saks, Mari Punab, Kjeld Schmiegelow
Journal: Blood
Blood (2018) 131 (22): 2475–2484.
https://doi.org/10.1182/blood-2018-01-827949
Published: 2018
Includes: Supplemental data
Journal Articles

Thromboembolism in ALL Patients 1-45 Years Treated According to the NOPHO-ALL 2008 Protocol

Cecilie Rank, MD, Nina Toft, MD PhD, Ruta Tuckuviene, MD PhD, Kathrine Grell, PhD, Ove Juul Nielsen, MD DMSc, Thomas Leth Frandsen, MD PhD, Ulf Tedgaard, MD PhD, Helene Hallböök, MD PhD, Ellen Ruud, MD PhD, Petter Quist-Paulsen, MD PhD, Kaisa Vepsäläinen, MD, Ulla Wartiovaara-Kautto, MD PhD, Ólafur G. Jónsson, MD, Sonata Saulyte Trakymiene, MD, Laimonas Griškevičius, MD PhD, Kadri Saks, MD, Mari Punab, MD, Kjeld Schmiegelow, MD DMSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 2564.
https://doi.org/10.1182/blood.V130.Suppl_1.2564.2564
Published: 2017
Journal Articles

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

Clinical Trials & Observations
Sif Gudbrandsdottir, Henrik Sverre Birgens, Henrik Frederiksen, Bjarne Anker Jensen, Morten Krogh Jensen, Lars Kjeldsen, Tobias Wirenfeldt Klausen, Herdis Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Ove Juul Nielsen, Torben Plesner, Stanislaw Pulczynski, Inge Helleberg Rasmussen, Dorthe Rønnov-Jessen, Hans Carl Hasselbalch
Journal: Blood
Blood (2013) 121 (11): 1976–1981.
https://doi.org/10.1182/blood-2012-09-455691
Published: 2013
Includes: Supplemental data
Journal Articles

Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin

Brief Report
Maciej Bogdan Maniecki, Henrik Hasle, Lennart Friis-Hansen, Birgitte Lausen, Ove Juul Nielsen, Knud Bendix, Søren Kragh Moestrup, Holger Jon Møller
Journal: Blood
Blood (2008) 112 (4): 1510–1514.
https://doi.org/10.1182/blood-2007-09-114165
Published: 2008
Includes: Supplemental data
Journal Articles

Immunogenicity of Bcl-2 in patients with cancer

Mads Hald Andersen, Inge Marie Svane, Pia Kvistborg, Ove Juul Nielsen, Eva Balslev, Sine Reker, Jürgen C. Becker, Per thor Straten
Journal: Blood
Blood (2005) 105 (2): 728–734.
https://doi.org/10.1182/blood-2004-07-2548
Published: 2005